Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR101 vs Ryzodeg in Type 2 Diabetes Mellitus (Phase 2, China)
CTR20232521Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Aug 2023
- Modality
- Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GZR101 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Aug 2023; status: completed.
02
Drugs
GZR101
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20232521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232521.